Clinical Trial Update: The Efficacy of Allo-HSCT in ND HR-CBF-AML

View source ↗

Summary

A clinical trial sponsored by Ruijin Hospital is evaluating the efficacy of allogeneic hematopoietic stem cell transplantation in newly diagnosed high-risk core…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Allogeneic hematopoietic stem cell transplantation

Snippet

Sponsor: Ruijin Hospital | Conditions: Acute Myeloid Leukemia | Status: RECRUITING